[144] Insulet Corporation SEC Filing
Insulet Corporation (PODD) Form 144 notifies of a proposed sale of 687 common shares through Fidelity Brokerage Services with an aggregate market value of $238,718.01, planned for 09/08/2025 on NASDAQ. The shares were acquired by the filer via restricted stock vesting as compensation on 01/10/2025 (308 shares) and 02/27/2025 (379 shares).
The filing also discloses prior sales by the same person, Prem Singh: 2,327 shares sold on 06/13/2025 for $698,216.35 and 1,343 shares sold on 08/07/2025 for $429,760.00. The notice includes the required representation that the seller is not aware of undisclosed material adverse information.
- Transparency: The filing discloses acquisition dates, nature of acquisition, broker, planned sale date, and past sales, meeting Rule 144 reporting requirements
- Compensation origin: Shares to be sold were acquired via restricted stock vesting, indicating they resulted from issuer compensation rather than external purchase
- Insider sales: The filer has sold 3,670 shares in the past three months, which may be interpreted by some investors as disposition of holdings
- No 10b5-1 plan disclosed: The filing does not indicate adoption of a written trading plan or date, so sales may be viewed as discretionary
Insights
TL;DR: Routine insider sale notice showing vested restricted shares proposed for sale; prior voluntary sales also disclosed.
This Form 144 documents a planned open-market sale of 687 vested shares valued at $238,718.01, consistent with compensation-related share vesting earlier in 2025. The filing is procedural and provides transparency about timing, broker, and past sales by the same person totaling 3,670 shares in the last three months. There is no additional financial or operational disclosure in this filing to assess company fundamentals.
TL;DR: Filing appears to meet Rule 144 disclosure requirements and includes the seller's attestation about material information.
The notice identifies acquisition dates, nature of acquisition (restricted stock vesting), payment as compensation, broker details, and past sales with gross proceeds, fulfilling key Rule 144 reporting elements. The seller's signature block includes the standard representation regarding knowledge of undisclosed material adverse information, as required for compliance. No indication of a 10b5-1 plan is provided in the content.